2019). Additionally, recent studies have demonstrated that irisin can also enhance cognition in patients with VD, frontotemporal dementia (FTD), and Parkinson's disease (PD) (Fraga et al. 2021; Guo et al. 2024). Here, FNDC5 is linked to frontotemporal dementia.